Status | Study |
Not yet recruiting |
Study Name: Triheptanoin in Mc Ardle Condition: Glycogen Storage Disease Type V Date: 2016-09-28 Interventions: Drug: Triheptanoin Anaplerotic |
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition: Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
Active, not recruiting |
Study Name: Sodium Valproate for GSDV Condition: Glycogen Storage Disease Type V McArdle D Date: 2015-08-11 Interventions: Drug: Sodium Valproate Subjects will receive sodium valproate modified release 20mg/kg/day (maximum dose |
Recruiting |
Study Name: Biomarker for Glycogen Storage Diseases Condition: Fructose Metabolism, Inborn Errors Glycogen Storage Disease Date: 2015-03-02 |
Recruiting |
Study Name: The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) Condition: Glycogen Storage Disease Type V Date: 2014-11-04 Interventions: Drug: Triheptanoin Anaplerotic |
Recruiting |
Study Name: The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies Condition: Muscular Dystrophies Date: 2008-05-06 Interventions: Radiation: Far Infrared Radiation Radiation: Far Infrared Radiation (5μm to 20μm wavelength) F |